/

/

Transcriptome Profiling for High-Throughput Drug Screening

/

Legemiddelscreening ved bruk av mononukleære celler i perifert blod (PBMC) og cellelysatpreparat for mRNA-sekvensering

JoVE Journal
Biology

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Biology

Drug Screening Using Peripheral Blood Mononuclear Cells (PBMCs) and Cell Lysate Preparation for mRNA Sequencing

Legemiddelscreening ved bruk av mononukleære celler i perifert blod (PBMC) og cellelysatpreparat for mRNA-sekvensering

Transcriptome Profiling for High-Throughput Drug Screening

DOI:

10.3791/200934-v

•

01:56 min

•

February 23, 2024

•

Jacqueline Leidner², Heidi Theis, Michael Kraut, Alice Ragogna, Marc Beyer^3,4, Joachim Schultze^2,3, Jonas Schulte-Schrepping², Caterina Carraro², Lorenzo Bonaguro²

¹Systems Medicine,German Center for Neurodegenerative Diseases (DZNE) eV., ²Genomics & Immunoregulation, LIMES Institute,University of Bonn, ³PRECISE Platform for Single Cell Genomics and Epigenomics,DZNE and University of Bonn, ⁴Immunogenomics & Neurodegeneration,German Center for Neurodegenerative Diseases (DZNE) eV.

Tags

PBMC Cell Lysate MRNA Sequencing Drug Screening Cell Culture Cell Counting Trypan Blue Cell Suspension Cell Viability 96-well Plate Cell Lysis PBS Lysis Buffer PCR Plate

Embed

ADD TO PLAYLIST

Usage Statistics

Related Videos

Kostnadseffektiv transkriptomisk basert legemiddelscreening

Legemiddelscreening ved bruk av mononukleære celler i perifert blod (PBMC) og cellelysatpreparat for mRNA-sekvensering

cDNA Library Forberedelse fra stoffet behandlet-perifert blod mononukleær celle (PBMC) lysat for mRNA-sekvensering

mRNA-sekvensering for å forstå den cellulære effekten av medikamentell behandling

Read Article